Author: Ewan Hartford - Page 2

The Hatch-Waxman Act balances brand-name innovation with generic competition. Learn how ANDAs, the Orange Book, and patent challenges drive down drug costs.

Explore the cost differences between authorized generics and first-to-file generics. Learn how market exclusivity, FTC data, and competition impact drug prices for patients and pharmacies.

Learn how manufacturer copay assistance cards work, who qualifies, and how to avoid hidden costs from copay accumulator programs. Compare options and maximize savings on brand-name prescriptions.

Learn how to legally obtain Valium (diazepam) online through licensed telehealth providers. Discover safe platforms, cost comparisons between generic and brand names, and critical safety warnings against illegal pharmacies.

Combining NSAIDs and blood thinners drastically increases bleeding risk. Learn the specific dangers, safer alternatives like acetaminophen, and expert guidelines to manage pain safely without harming your health.

Heavy menstrual bleeding affects up to 70% of women on blood thinners. Learn safe management options including hormonal therapies, tranexamic acid, and iron supplementation without stopping your anticoagulant medication.

Learn how to perform precise pediatric weight-based dosing calculations and implement safety double-checks to prevent medication errors in children.

Explore the legal basis and FDA approval process for generic drugs, from the Hatch-Waxman Act and ANDA pathways to bioequivalence and patent challenges.

Explore the balance between the rapid inflammation relief of corticosteroids and the serious long-term risks like osteoporosis and diabetes. Learn about tapering and safety.

Learn about the metabolic risks of antipsychotic medications, including weight gain and diabetes, and discover the essential monitoring guidelines to protect your health.

Explore the additive sedation risks of combining cannabis with CNS depressants like benzodiazepines and opioids, including safety tips and medical warnings.

Learn how the FDA uses the ANDA process and bioequivalence testing to approve safe, affordable generic drugs under the Hatch-Waxman Act.